Elevated MICs of susceptible antipseudomonal cephalosporins in non-carbapenemase-producing, carbapenem-resistant Pseudomonas aeruginosa: Implications for dose optimization

Authors

Christian M Gill, Hartford Hospital
Carey-Ann D Burnham, Washington University School of Medicine in St. Louis
et al

Journal

Antimicrobial agents and chemotherapy

Publication Date

10-18-2021

Volume

65

Issue

11

First Page

e0120421

Document Type

Open Access Publication

DOI

10.1128/AAC.01204-21

Rights and Permissions

Gill CM, Aktaş E, Alfouzan W, Bourassa L, Brink A, Burnham CD, Canton R, Carmeli Y, Falcone M, Kiffer C, Marchese A, Martinez O, Pournaras S, Seifert H, Thabit AK, Villegas MV, Westblade LF, Nicolau DP; ERACE-PA Global Study Group. Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0120421. doi: 10.1128/AAC.01204-21.

Recommended Citation

Gill, Christian M; Burnham, Carey-Ann D; and et al, "Elevated MICs of susceptible antipseudomonal cephalosporins in non-carbapenemase-producing, carbapenem-resistant Pseudomonas aeruginosa: Implications for dose optimization." Antimicrobial agents and chemotherapy. 65, 11. e0120421 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11395